Remington-Davis

Executive Summary

Remington-Davis is an independent clinical research site and trial management partner based in Columbus, Ohio, with over 35 years of experience in conducting Phase I-IV clinical trials. Founded in 1989, the company specializes in rapid patient recruitment and enrollment, leveraging a diverse patient database and efficient study start-up processes to accelerate timelines for pharmaceutical sponsors. Its patient-centric approach and comprehensive site management services make it a valuable partner for biopharma companies seeking to streamline clinical development. Operating across multiple therapeutic areas, including oncology, Remington-Davis has built a reputation for reliability and speed in a competitive CRO landscape. As a private, independently operated site, Remington-Davis benefits from the growing trend of outsourcing clinical trial operations to specialized providers. The company's ability to deliver high-quality data on time and within budget positions it for continued relevance, though its growth is constrained by the need to continuously secure new trial contracts. With no disclosed financials or upcoming milestones, its performance hinges on maintaining strong relationships with sponsors and expanding its service offerings. The company's modest size and focus on a single geographic region may limit scalability, but its established track record provides a stable foundation for future opportunities, particularly as decentralized trial models gain traction.

Upcoming Catalysts (preview)

• 2026New multi-year contract with a top-20 pharma sponsor70% success
• Q4 2026Expansion into decentralized trial capabilities60% success
• Q3 2026Award of a high-profile oncology trial contract65% success